Chinese Herbal Medicines is now indexed in PubMed Central (PMC)

Recently, Chinese Herbal Medicines (CHM), an open access journal sponsored by Tianjin Institute of Pharmaceutical Research (TIPR) and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences (CAMS), has been officially accepted and indexed in PubMed Central (PMC) of the U.S. National Institutes of Health and the National Library of Medicine (NIH/NLM).

The inclusion of CHM in PMC is a certification of the quality of the journal, which means that the journal quality and open access policy of CHM have reached international standards and are of great significance in promoting the dissemination, improving international exposure and enhancing academic influence of the journal. Global readers can access all articles of the journal since 2020 for free in the PMC database at https://www.ncbi.nlm.nih.gov/pmc/journals/4291/.

PMC is a Web-based biomedical information retrieval system developed by the National Center for Biotechnology Information (NCBI), a division of the U.S. National Library of Medicine (NLM) and is freely available worldwide. Free access to the full text of all journals is the core principle of PMC, which is truly the world's most authoritative biomedical OA journal database with the highest utilization rate for searching biomedical literature in the world. The inclusion of PMC is of great significance to improve the international academic influence of journals.

Introduction of CHM

Chinese Herbal Medicines, sponsored by TIPR and Institute of Medicinal Plant Development of CAMS and published by Tianjin Press of Chinese Herbal Medicines, was officially founded in October, 2009. The honorary editors-in-chief are Professor Peigen Xiao, academician of the Chinese Academy of Engineering (CAE) and honorary director of the Institute of Medicinal Plants of CAMS, and Professor Yungchi Cheng, Chair Professor of pharmacology at Yale University, USA; Professor Changxiao Liu, academician of CAE and honorary president of TIPR, and Professor Luqi Huang, academician of CAE and president of China Academy of Chinese Medical Sciences are co-editors-in-chief.

Since 2013, CHM has been selected as one of the Chinese Core Periodicals of Science and Technology for nine consecutive years. In 2017, CHM was indexed in the Emerging Sources Citation Index (ESCI) database (Articles published by CHM since 2015 can be retrieved in Web of Science database), making significant progress in the internationalization of CHM. In the World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals published in 2018 and 2019, CHM was included as the Q2 journal of the discipline of "Integrative and Complementary Medicine" for two consecutive years. In 2019, CHM was successfully selected by China Association for Science and Technology for the China Science and Technology Journal Excellence Action Plan. And CHM was indexed in Scopus database and DOAJ in 2020.

In 2018, CHM began to cooperate with Elsevier Publishing Group (Journal homepage: https:// www.elsevier.com/locate/chmed), and the co-published articles will be published online on ScienceDirect, a famous academic database platform, which can improve the timeliness of publication and the international exposure and visibility of articles. Since 2020, CHM has been working with Elsevier Publishing Group on Open Access co-publication. Currently, all articles of the journal since 2013 are available on the Elsevier SD full-text publishing platform (https://www.sciencedirect.com/journal/chinese-herbal-medicines). With the Elsevier SD academic platform and ScholarOne submission and review system (Submission link: https://mc03.manuscriptcentral.com/chm), CHM absorbs high-quality manuscripts from home and abroad to improve the academic quality of the journal; Insists on the international standard layout, strengthens the standardization of the journal, and pays attention to the exchange and cooperation with international famous scientific and technical journals.

We believe that PMC inclusion will provide higher exposure of articles published in CHM. At the same time, CHM will continue to maintain the policy of Open Access publication, continuously improve the academic quality of published articles. We highly encourage your submission to CHM.

The editorial office of CHM here would like to express sincere appreciation for the enthusiastic and vigorous support and contributions from all editorial board members, reviewers, youth editorial board members, authors, and readers.

Journal homepage: https:// www.elsevier.com/locate/chmed

Submitting Welcome at: https://mc03.manuscriptcentral.com/chm

Email: chmtianjin@126.com

Tel: 022-23006901